FOXO4-DRI Made in USA — Third-Party Verified
FOXO4-DRI is a specialized D-retro-inverso peptide synthesized to target and disrupt p53-FOXO4 protein-protein interactions in cellular senescence assays. Manufactured in domestic, GMP-compliant facilities and tested in ISO 17025 accredited analytical laboratories, PX1 Research provides verified FOXO4-DRI made in USA for precision in vitro and preclinical research applications. Each lot undergoes comprehensive high-performance liquid chromatography (HPLC) and mass spectrometry (MS) verification to guarantee consistent analytical standards.
Quick answer
FOXO4-DRI is a specialized D-retro-inverso peptide synthesized to target and disrupt p53-FOXO4 protein-protein interactions in cellular senescence assays. Manufactured in domestic, GMP-compliant facilities and tested in ISO 17025 accredited analytical laboratories, PX1 Research provides verified FOXO4-DRI made in USA for precision in vitro and preclinical research applications. Each lot undergoes comprehensive high-performance liquid chromatography (HPLC) and mass spectrometry (MS) verification to guarantee consistent analytical standards.
Key takeaways
- In modern cell biology and molecular research, batch-to-batch reproducibility is essential when investigating complex signaling networks.
- FOXO4-DRI (Forkhead Box O4 D-Retro-Inverso) is designed as a modified peptide mimetic targeting specific intracellular domain interactions.
- Cellular senescence is defined by stable cell cycle arrest, metabolic altered states, and the expression of a pro-inflammatory senescence-associated secretory phenotype (SASP).
- To guarantee that research results are attributable solely to the target sequence, rigorous third-party analytical verification is mandatory.
Domestic Synthesis Standards for FOXO4-DRI Research Peptides
In modern cell biology and molecular research, batch-to-batch reproducibility is essential when investigating complex signaling networks. Obtaining reliable FOXO4-DRI made in USA ensures that investigators bypass the chemical inconsistencies, variable sequence purity, and degradation associated with unverified overseas production. PX1 Research synthesizes all custom sequences and catalog items in USA-based, GMP-compliant facilities adhering to rigid quality management systems.
Domestic synthesis provides direct oversight of solid-phase peptide synthesis (SPPS) parameters, including coupling efficiency, cleavage condition optimization, and resin selection. Because FOXO4-DRI is a retro-inverso peptide composed of D-amino acids, precise stereochemical control during synthesis is mandatory to prevent racemization. By maintaining strict control within domestic facilities, PX1 Research ensures that every batch meets exact sequence specifications for high-stringency research applications.
Molecular Dynamics and Chemical Structure of FOXO4-DRI
FOXO4-DRI (Forkhead Box O4 D-Retro-Inverso) is designed as a modified peptide mimetic targeting specific intracellular domain interactions. The unmodified wild-type L-peptide sequence is prone to rapid enzymatic cleavage by endopeptidases and exopeptidases within serum and cell culture media. To overcome this limitation in long-duration assays, researchers utilize a D-retro-inverso design, reversing the amino acid sequence direction and substituting naturally occurring L-amino acids with their D-enantiomers.
This structural inversion maintains the spatial side-chain topology necessary to bind target domains while conferring significant resistance to proteolysis. Preclinical data indicate that this conformation allows FOXO4-DRI to remain structurally intact during extended incubation periods in vitro. Investigating this unique sequence topology provides critical insights into targeting protein-protein interfaces that were historically deemed un-targetable by conventional small molecules.
Preclinical Applications in Cellular Senescence and Apoptosis Research
Cellular senescence is defined by stable cell cycle arrest, metabolic altered states, and the expression of a pro-inflammatory senescence-associated secretory phenotype (SASP). In senescent cells, the tumor suppressor p53 is frequently retained in the nucleus via interactions with FOXO4, preventing p53 from translocating to the mitochondria to initiate nuclear or mitochondrial apoptotic signaling cascades.
In vitro models demonstrate that FOXO4-DRI acts as a competitive antagonist against the endogenous FOXO4 binding site on p53. By occupying this binding interface, the peptide facilitates the release of p53, allowing it to migrate to the mitochondria and trigger cell death pathways specifically within target senescent populations. Research models show that non-senescent, metabolically active control cells remain unaffected by this inhibition, rendering FOXO4-DRI a central tool for mapping senolytic mechanisms and targeted cell-clearance assays.
ISO 17025 Analytical Verification: HPLC, MS, and Endotoxin Testing
To guarantee that research results are attributable solely to the target sequence, rigorous third-party analytical verification is mandatory. Every lot of FOXO4-DRI made in USA by PX1 Research undergoes strict chemical analysis at an independent ISO 17025 accredited laboratory prior to release. Certificates of Analysis (COAs) containing full chromatograms and spectral data are published directly for research transparency.
Analytical protocols include high-performance liquid chromatography (HPLC) to confirm sequence purity exceeding 98%, ensuring the absence of truncated sequences or deletion mimetics. Matrix-assisted laser desorption/ionization or electrospray ionization mass spectrometry (ESI-MS) confirms the exact molecular weight and isotopic distribution. Furthermore, chromogenic Limulus Amebocyte Lysate (LAL) testing guarantees that endotoxin levels remain strictly controlled below 0.1 EU/mg, protecting sensitive primary cell cultures and organoid models from unwanted inflammatory stimulation.
Comparative Analysis: Senolytic and Mitochondrial Research Peptides
When designing preclinical protocols to evaluate cellular longevity, metabolic regulation, and stress response pathways, investigators often contrast FOXO4-DRI with other established research compounds. While FOXO4-DRI specifically interferes with p53-mediated nuclear retention in senescent cells, compounds like SS-31 focus on stabilizing mitochondrial cristae architecture and reducing inner-membrane reactive oxygen species (ROS). Similarly, Epitalon is studied for its influence on telomerase activity and chromatin organization, whereas MOTS-c operates as a mitochondrial-derived peptide regulating metabolic homeostasis and AMP-activated protein kinase (AMPK) pathways.
Comparing these distinct mechanisms allows researchers to construct multi-targeted in vitro models to explore how mitochondrial support, telomeric dynamics, and targeted senolysis intersect within complex biological systems. Choosing verified, USA-synthesized peptides ensures that comparative assays yield robust, reproducible metrics without baseline distortion caused by impurities.
Laboratory Handling, Reconstitution, and Storage Protocols
FOXO4-DRI is supplied as a lyophilized (freeze-dried) powder to maximize long-term chemical stability. To prepare the compound for laboratory experimentation, appropriate liquid handling protocols must be observed under sterile laminar flow conditions. Reconstitution parameters depend on the targeted assay concentrations and buffer compatibility.
Researchers typically reconstitute lyophilized FOXO4-DRI using sterile, endotoxin-free bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Gentle agitation or light vortexing may be applied to dissolve the peptide cake completely; violent agitation should be avoided to minimize mechanical shear stress. For long-term storage, reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes and stored at -20°C or -80°C to prevent freeze-thaw degradation.
Supply Chain Integrity and Fast Cold-Chain Logistics
Chemical stability during transit is a primary concern when procuring delicate research reagents. Lyophilized peptides exposed to elevated ambient temperatures during international transit can undergo thermal degradation, leading to aggregation or cleavage prior to receipt.
PX1 Research eliminates shipping vulnerabilities by managing centralized, temperature-controlled distribution centers in California and Arizona. Orders containing FOXO4-DRI made in USA are processed with same-day dispatch (Monday through Friday) using thermal-insulated packaging and specialized cold packs. This rigorous domestic cold-chain infrastructure preserves the structural integrity of every vial from the synthesis facility directly to your laboratory bench.
Procurement for Academic and Industrial Institutional Accounts
PX1 Research supports university research departments, biotechnology firms, and contract research organizations (CROs) requiring dependable supply channels for high-purity peptides. Institutional purchasing demands transparent documentation, rapid lot traceability, and consistent batch manufacturing.
Laboratories conducting high-throughput screening or large-scale preclinical studies can access custom synthesis, bulk pricing structures, and dedicated account support through the PX1 Research wholesale portal. Our technical support team works directly with principal investigators and lab managers to ensure all analytical specifications align with project requirements.
Frequently Asked Questions
Where is PX1 Research's FOXO4-DRI synthesized?
All FOXO4-DRI research peptides offered by PX1 Research are synthesized domestically in cGMP-compliant facilities located in the United States.
How is the purity of FOXO4-DRI verified?
Every manufacturing lot undergoes independent third-party testing in an ISO 17025 accredited laboratory. Purity is verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), with complete Certificates of Analysis (COAs) provided for each batch.
What are the endotoxin limits for PX1 Research FOXO4-DRI?
PX1 Research enforces strict endotoxin controls, confirming levels below 0.1 EU/mg using standardized chromogenic LAL assays to prevent cell culture contamination or non-specific inflammatory responses.
What solvent should be used to reconstitute FOXO4-DRI for in vitro assays?
FOXO4-DRI is typically reconstituted using sterile, endotoxin-free bacteriostatic water or sterile PBS (pH 7.4), depending on the specific requirements of the cell culture media or assay buffer system.
How should lyophilized and reconstituted FOXO4-DRI be stored?
Lyophilized FOXO4-DRI should be stored at -20°C upon receipt for long-term stability. Once reconstituted, stock solutions should be aliquoted into single-use vials and frozen at -20°C or -80°C to avoid repeated freeze-thaw cycles.
What makes the retro-inverso structure of FOXO4-DRI advantageous in research?
The D-retro-inverso modification reverses the amino acid sequence and utilizes D-enantiomers, making the peptide highly resistant to enzymatic degradation by proteases in experimental media while preserving target binding specificity.
How fast does PX1 Research ship FOXO4-DRI orders within the USA?
Orders placed Monday through Friday ship same-day from domestic distribution facilities in California and Arizona, utilizing temperature-controlled packaging to protect compound integrity.
Can academic labs purchase bulk quantities of FOXO4-DRI?
Yes, PX1 Research provides institutional accounts, custom lot reservation, and bulk procurement options for qualified university and industrial research facilities via our wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.